Shionogi And GSK HIV Drug To Enter Phase III
This article was originally published in PharmAsia News
Executive Summary
Shionogi and GlaxoSmithKline July 21 announced a plan to start a Phase III study for investigational integrase inhibitor S/GSK1349572 within the year